Stocks News

LAST PRICE
0.6500
TODAY'S CHANGE (%)
Trending Down-0.0400 (-5.7971%)

Bid / Lots
0.1500/ 100
Ask / Lots
1.0000/ 10
Open / Previous Close
0.3490 / 0.6900
Day Range
Low 0.1390
High 0.6950
52 Week Range
Low 0.0002
High 0.7500
Volume
67,049
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

No documents available

Nov 3, 2024
- INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC, from 3:49PM ET on Sunday Nov 03, 2024 by PR Newswire
  3:49PM ET on Sunday Nov 03, 2024 by PR Newswire
  Companies Mentioned: GLYC
- INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC, from 3:49PM ET on Sunday Nov 03, 2024 by Dow Jones
  3:49PM ET on Sunday Nov 03, 2024 by Dow Jones
  Companies Mentioned: GLYC
Nov 1, 2024
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders, from 12:04PM ET on Friday Nov 01, 2024 by PR Newswire
  12:04PM ET on Friday Nov 01, 2024 by PR Newswire
  Companies Mentioned: USAP, ALTR, GLYC
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders, from 12:04PM ET on Friday Nov 01, 2024 by Dow Jones
  12:04PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: USAP, ALTR, GLYC
Oct 31, 2024
- GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC, from 11:57AM ET on Thursday Oct 31, 2024 by Dow Jones
  11:57AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: GLYC
Oct 30, 2024
- Enlivex Therapeutics Gets Japan Patent Notice for Allocetra in Osteoarthritis Treatment, from 11:09AM ET on Wednesday Oct 30, 2024 by MT Newswires
  11:09AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: ENLV
- Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm, from 9:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  9:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: RCM, PFIE, GLYC, RVNC
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders, from 9:15AM ET on Wednesday Oct 30, 2024 by Dow Jones
  9:15AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ZUO, PFIE, GLYC
- Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra(TM) in Patients with Osteoarthritis, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ENLV
- Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update, from 7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: CMMB

Cell Source Inc
OTCQB:CLCSUnited States

Search Criteria

Peers Headlines

Nov 3, 2024

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC, from 3:49PM ET on Sunday Nov 03, 2024 by PR Newswire

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC, from 3:49PM ET on Sunday Nov 03, 2024 by Dow Jones

Nov 1, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders, from 12:04PM ET on Friday Nov 01, 2024 by PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders, from 12:04PM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC, from 11:57AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

Enlivex Therapeutics Gets Japan Patent Notice for Allocetra in Osteoarthritis Treatment, from 11:09AM ET on Wednesday Oct 30, 2024 by MT Newswires

Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm, from 9:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders, from 9:15AM ET on Wednesday Oct 30, 2024 by Dow Jones

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra(TM) in Patients with Osteoarthritis, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones

Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update, from 7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones